The synthesis of several (2-oxaadamant-1-yl)amines is reported. They were evaluated as NMDA receptor antagonists and several of them were more active than amantadine, but none was more potent than memantine. None of the tested compounds displayed antiviral activity. Two of the derivatives showed a significant level of trypanocidal activity.
Introduction
1-Adamantylamine (amantadine) and its 3,5-dimethyl analogue, memantine, are NMDA receptor antagonists approved for the treatment of Parkinson's and Alzheimer's disease, respectively. 1 Amantadine also has prophylactic and therapeutic activities in influenza A virus infections 2 , and related adamantane derivatives show antiviral activity. 3 Moreover, amantadine, memantine, and related polycyclic amines possess trypanocidal properties. 4 It is well known in medicinal chemistry that substitution of a methylene unit in a bioactive compound for an oxygen atom usually leads to analogues showing similar activity to the parent compound. 5 Indeed, NGP1-01, a brain-permeable, oxa-polycyclic cage amine, is a dual action uncompetitive NMDA receptor antagonist and blocker of L-type calcium-channels. In addition, several experiments have shown that NGP1-01 has neuroprotective activity (Fig. 1) . 6 Based on the interesting and widely observed biological activity of amantadine, memantine, and NGP1-01, we therefore sought to explore the biological profile of (2-oxaadamant-1-yl)amine derivatives.
In this paper, we report the synthesis of several (2-oxaadamant-1-yl)amines and related compounds and their pharmacological evaluation as NMDA receptor antagonists, and antivirals and trypanocidals agents.
Results and discussion

Chemistry
Starting from the known diketone 1, 7 we have prepared amines 2À4, 7, 8, and 10À15 using classical methods in amine chemistry (see Scheme 1). 0968 Secondary amines 2a and 2b were obtained in high yields following a known general procedure that involves reductive amination of diketone 1. 8 Thus, reaction of 1 with benzylamine followed by reduction with LiAlH 4 led to amine 2a in 58% yield. Similarly, reductive amination of 1 with phenethylamine furnished amine 2b in 51% yield. Reductive alkylation of amines 2a,b with formaldehyde and sodium cyanoborohydride afforded tertiary amines 3a,b in high yields. Hydrogenolysis of the benzyl group of amines 2a and 3a led to 7 and 4, respectively. Finally, alkylation of 2a with benzyl chloride led to 8 in 85% yield.
Alcohols of general structure 5 were prepared using a general method developed some time ago by our group. 9 Several attempts to carry out the substitution of the hydroxyl group of 5 by a wide range of amines led to the recovery of the starting material. Moreover, the attempted Ritter reaction of 5c with acetonitrile in acidic medium led to the known enone 6 in high yield. 9c However, reaction of 5a-c with aqueous hydrazine led to hydrazines 9a-c in high yields, probably due to the a-effect ensuring a higher nucleophilicity of hydrazine. Even though the reaction failed in the case of 5d.
Catalytic hydrogenation of 9a,b furnished amines 10a,b in high yields. Surprisingly, 9c led to a mixture of the expected amine 10c and the cyclohexyl derivative 10d in the ratio of 3:4. Both products were separated by column chromatography. Reductive methylation of amines 10a and 10b with formaldehyde and sodium cyanoborohydride afforded tertiary amines 11a and 11b, respectively. In a similar way, reductive alkylation of 10b with acetaldehyde or benzaldehyde led to amines 12 and 13, respectively. Finally, secondary amine 15 was synthesized from benzylamine 13 by reductive alkylation followed by catalytic debenzylation in good overall yield.
The structure of all new compounds was confirmed by elemental analysis or by accurate mass measurement, IR, 1 H NMR, 13 C NMR, and mass spectral data.
NMDA receptor antagonist activity
In the last years there has been an intensive research on the development of new NMDA receptor antagonists, since this sub- type of receptors has been involved in the apoptotic process that develops during neurodegenerative diseases. Memantine is a non-competitive and low affinity blocker that acts selectively on NMDA receptors that is being used in Alzheimer's disease to slow down its progression. 10 The activity of the different (2-oxaadamant-1-yl)amines was assayed on cerebellar granule neurons loaded with the calcium-sensitive probe Fura-2. 11 Addition of glutamate or NMDA (100 lM) in the presence of glycine (10 lM) produced a robust and stable increase in intracellular calcium that was challenged with cumulative additions of the compounds to be tested. The data presented in Table 1 indicate that the presence of a substituent in C-3 in the 2-oxaadamantane nucleus is essential for NMDA receptor antagonism. Thus, primary amine 7 and all its N-alkylated and Ndialkylated derivatives (2a,b, 3a,b, 4, and 8) are inactive as it is the case of the methyl derivatives 10a and 11a. Phenyl derivative 10c is only a weak NMDA receptor antagonist while more lipophilic amines 10b and 10d show a similar potency than amantadine. Further enhancement in potency was achieved by alkylation of 10b, the most active derivative being 12, a tertiary amine that is seven times more potent than amantadine, but still ten times less potent than memantine. Contrary to our expectations, all the benzyl derivatives were found to be inactive. This is in striking contrast with NGP1-01 that features a benzyl group essential for NMDA receptor antagonism, and with previous work by our groups that found that benzylated ring-contracted analogues of amantadine showed NMDA receptor antagonism. 12
Antiviral activity
Primary amines 7, 10c, and 10d and secondary amines 2a, 4, and 15 were tested for antiviral activity. None of the tested compounds displayed activity against the enveloped DNA viruses herpes simplex virus (type 1 or type 2) or vaccinia virus; the enveloped RNA viruses feline coronavirus, parainfluenza-3 virus, respiratory syncytial virus, vesicular stomatitis virus, sindbis virus, or Punta Toro virus; or the non-enveloped RNA viruses Coxsackievirus B4 and Reovirus-1. Also none of the compounds was found to be active against influenza virus A/H1N1, A/H3N2, or B.
Trypanocidal activity
Protozoan parasites of the Trypanosoma brucei species complex are the causative agents of African trypanosomiasis, a disease that is invariably fatal unless treated. However, current drugs are characterized by toxicity, the need for administration under medical supervision, and in many cases, a lack of efficacy. New drugs to combat this important disease are urgently needed. A range of adamantylamine compounds have trypanocidal activity. 4 We therefore investigated whether this property also extended to (2oxaadamant-1-yl)amine derivatives.
All the new derivatives described in this paper were tested for potency against cultured bloodstream form T. brucei. As was the case with the NMDA receptor antagonism, the presence of a substitution at the C-3 position in the 2-oxadamantane nucleus was found to be essential for trypanocidal activity. Of these compounds, the tertiary amines 11a,b were found to be the most active. Amine 11b had an IC 50 = 10.92 ± 0.21 lM and an IC 90 = 15.54 ± 1.14 lM, while the trimethyl derivative 11a had an IC 50 = 3.97 ± 0.75 lM and an IC 90 = 6.82 ± 0.84 lM. Amine 11a was the most potent compound tested, being approximately twice as active as rimantadine (IC 50 = 7.04 ± 0.12 lM; IC 90 = 13.97 ± 1.68 lM), and at least 30 times more active than amantadine (IC 50 > 130 lM). Amines 2a, b, 3a, b, 4, 7 , and 8, which lack the C3 substitution, had no activity at concentrations up to 5 mg mL À1 . The primary and secondary amines 10a-d, 13, and 15 also displayed no significant trypanocidal properties, even though they do carry a substitution at this position.
Several adamantane derivatives have previously been shown to have trypanocidal properties; however the oxanalogues reported here are the first heteroadamantanes to show significant activity against bloodstream form T. brucei. 4
Conclusions
In summary, we have synthesized and fully characterized several (2-oxaadamant-1-yl)amines. The presence of a substitution at the C-3 position is essential for NMDA receptor antagonism. Although 11b, 12, and 15 were more potent than amantadine against NMDA-induced calcium increase in cerebellar granule neurons, they were less potent than memantine. In contrast with the model compound NGP1-01, all our benzyl derivatives were devoid of NMDA receptor antagonism activity. None of the tested compounds showed antiviral activity. Two tertiary amines, 11a and 11b, displayed a significant level of trypanocidal activity; 11a was twice as active as rimantadine. The mechanism by which adamantylamine derivatives kill trypanosomes is unknown, but it has been hypothesized by analogy with the known properties of this class of compound that it may involve channel blocking activity. 4 The data obtained with the trimethyl amine 11a now provides a basis for exploring if related derivatives have enhanced activity.
The synthesis and pharmacological evaluation of more polycyclic cage amines are in progress.
Experimental
Chemistry
General
Melting points were determined in open capillary tubes. Unless otherwise stated, NMR spectra were recorded in CD 3 OD in the following spectrometers: 1 H NMR (500 MHz), 13 C NMR (75.4 MHz). Chemical shifts (d) are reported in ppm are related to internal tetramethylsilane (TMS). Assignments given for the NMR spectra are based on DEPT, COSY 1 H/ 1 H, HETCOR 1 H/ 13 C (HSQC and HMBC sequences for one bond and long range 1 H/ 13 C heterocorrelations, respectively), and NOESY experiments for selected compounds. For the MS and GC/MS analyses the sample was introduced directly or through a gas chromatograph. For GC/MS analyses, a 30-meter column [5% diphenyl-95% dimethylpolysiloxane, conditions: 10 
To a solution of diketone 1 (6.00 g, 39.4 mmol) in anhyd THF (200 mL), benzylamine (4.29 g, 40.0 mmol) was added and the solution was refluxed for 30 min. After cooling (ice-bath), this solution was added dropwise while stirring vigorously to a suspension of LiAlH 4 (3.00 g, 79.0 mmol) in anhyd diethyl ether (80 mL). The mixture was stirred for 6 h at 40°C and then, while cooling with an ice-bath, 1 N NaOH (19 mL) was added dropwise. The precipitate formed was filtered through Celite Ò , the clear filtrate was dried with anhyd Na 2 SO 4 , filtered, and concentrated in vacuo to give an oily residue (9.29 g). The residue was dissolved in acetone (120 mL), concd HCl (6 mL) was added and the solution was cooled at 4°C, whereupon 2a precipitated as its hydrochloride. Crystallization from 2-propanol gave pure 2aÁHCl (6.39 g, 58% yield), mp 257À259°C (lit. 8b 253À255°C). IR 2927 IR , 2852 IR , 2712 IR , 2606 IR , 2457 IR , 2408 IR , 2377 IR , 1569 IR , 1456 IR , 1323 IR , 1206 IR , 1194 IR , 1126 IR , 1093 IR , 1008 (9)], 45.1 (CH 2 , CH 2 -C 6 H 5 ), 73.6 (CH, C3), 86.6 (C, C1), 130.2 (CH, C meta ), 130.4 (CH, C para ), 131.1 (CH, C ortho ), 132.9 (C, C ipso ). MS (EI), m/z (%): 243 (M Å+ , 26), 200 (9), 186 (36), 149 (26), 106 (16), 91 (100). Anal. Calcd for C 16 H 21 NOÁHCl (279.81): C, 68.68; H, 7.92; N, 5.01; Cl, 12.67. Found: C, 68.51; H, 8.10; N, 5.00; Cl, 12.70. 4.1.3 
From 1 (3.00 g, 19.7 mmol), phenethylamine (2.55 g, 21.1 mmol) in anhyd THF (100 mL) and following the above procedure, the amine 2b was obtained as its hydrochloride (2.94 g, 51% yield), mp 256-259°C (2-propanol). IR 2934 IR , 2855 IR , 2721 IR , 2674 IR , 2617 IR , 2419 IR , 1604 IR , 1467 IR , 1455 IR , 1324 IR , 1209 IR , 1192 IR , 1093 IR , 1018 IR , 1001 To a solution of 2aÁHCl (838 mg, 3.00 mmol) in acetonitrile (20 mL), formaldehyde (2.36 mL, 37 wt % in water solution, 30 mmol) and NaBH 3 CN (595 mg, 9.00 mmol) were added. The mixture was stirred for 30 min at room temperature, acetic acid (0.6 mL) was added and the mixture was stirred at room temperature for 2 h. An additional portion of NaBH 3 CN (595 mg, 9.00 mmol) was added and the mixture was further stirred at room temperature for 2 h. The mixture was concentrated to dryness, 2 N NaOH (30 mL) was added and the suspension was extracted with CH 2 Cl 2 (3 Â 45 mL). The combined organic phases were washed with H 2 O (2 Â 30 mL), dried with anhyd Na 2 SO 4 , filtered, and concentrated in vacuo to give 3a (765 mg, 99% yield) as a white solid. The analytical sample was obtained by crystallization from CH 2 Cl 2 , mp 60À61°C (dec.). IR 2929 IR , 2897 IR , 2838 IR , 1456 IR , 1442 IR , 1381 IR , 1323 IR , 1190 , 9.01; N, 5.44. Found: C, 79.25; H, 9.11; N, 5.38. 4.1.5 . N-Methyl-N-(2-phenylethyl)(2-oxaadamant-1-yl)amine hydrochloride, 3b
To a solution of 2bÁHCl (257 mg, 1.00 mmol) in acetonitrile (10 mL), formaldehyde (0.78 mL, 37 wt % in water solution, 10 mmol) and NaBH 3 CN (188 mg, 3.00 mmol) were added. The mixture was stirred for 30 min at room temperature, acetic acid (0.3 mL) was added and the mixture was stirred at room temperature for 2 h. An additional portion of NaBH 3 CN (188 mg, 3.00 mmol) was added and the mixture was further stirred at room temperature for 2 h. The mixture was concentrated to dryness, 2 N NaOH (10 mL) was added and the suspension was extracted with CH 2 Cl 2 (3 Â 15 mL). The combined organic phases were washed with H 2 O (2 Â 10 mL), dried with anhyd Na 2 SO 4 , filtered, and concentrated in vacuo to give 3b (239 mg, 88% yield) as a white solid. Its hydrochloride was obtained by adding an excess of Et 2 OÁHCl to a solution of the amine in EtOAc. The analytical sample of 16ÁHCl was obtained by crystallization from EtOAc, mp 211À212°C. IR 2956 IR , 2915 IR , 2855 IR , 2596 IR , 2417 IR , 1481 IR , 1467 IR , 1454 IR , 1411 IR , 1376 IR , 1210 IR , 1086 IR , 1027 (9)], 51.6 (CH 2 , CH 2 N), 69.9 (CH, C3), 85.4 (C, C1), 125.7 (CH, Ar-C para ), 128.2 (CH) and 128.7 (CH) (Ar-C ortho and Ar-C meta ), 140.9 (C, Ar-C ipso ). MS (EI), m/z (%): 228 (2), 214 (2), 181 (13) A mixture of 3a (765 mg, 2.97 mmol) and 10% Pd/C (50% in water, 200 mg) in absolute EtOH (80 mL) was hydrogenated at 38 atm and 100°C for 24 h. The suspension was filtered, the residue was washed with EtOH, and to the combined organic filtrates an excess of Et 2 OÁHCl was added. Evaporation of the solvents from the filtrate in vacuo followed by crystallization from MeOH/Et 2 O gave 4ÁHCl (357 mg, 59% yield), mp 226-230°C. IR 2928 226-230°C. IR , 2856 226-230°C. IR , 2750 226-230°C. IR , 2694 226-230°C. IR , 2416 226-230°C. IR , 2372 226-230°C. IR , 1467 226-230°C. IR , 1209 226-230°C. IR , 1157 226-230°C. IR , 1097 226-230°C. IR , 1078 226-230°C. IR , 1023 , 57.18; H, 8.90; N, 6.67; Cl, 17.72. Found: C, 57.36; H, 8.77; N, 6.76; Cl, 17 .65.
(2-Oxaadamant-1-yl)amine hydrochloride, 7ÁHCl
A mixture of 2aÁHCl (2.20 g, 7.87 mmol) and 10% Pd/C (50% in water, 100 mg) in absolute EtOH (300 mL) was hydrogenated at 38 atm and 100°C for 24 h. The suspension was filtered, the residue was washed with EtOH, and the combined organic filtrates were concentrated in vacuo to give a solid. 2 N NaOH (25 mL) was added to the residue which was then extracted with EtOAc (3 Â 25 mL). The combined organic extracts were dried with anhyd Na 2 SO 4 , filtered, and concentrated in vacuo to give a residue that was sublimed at 60°C/2 Torr to give amine 7. Its hydrochloride (1.05 g, 70% yield) was obtained by adding an excess of a solution of HCl in MeOH to the amine, followed by concentration in vacuo. The analytical sample of 7ÁHCl was obtained by crystallization from MeOH, mp > 218°C (dec.). IR 3034, 2945 IR 3034, , 2851 IR 3034, , 2789 IR 3034, , 2744 IR 3034, , 2697 IR 3034, , 2631 IR 3034, , 2563 IR 3034, , 1578 IR 3034, , 1502 IR 3034, , 1384 IR 3034, , 1359 IR 3034, , 1329 IR 3034, , 1304 IR 3034, , 1211 IR 3034, , 1156 IR 3034, , 1016 , 56.99; H, 8.50; N, 7.38; Cl, 18.69. Found: C, 57.08; H, 8.61; N, 7.22; Cl, 18.54. 4.1.8 . N,N-Dibenzyl(2-oxaadamant-1-yl)amine, 8
A suspension of 2aÁHCl (280 mg, 1.00 mmol), K 2 CO 3 (690 mg, 5.00 mmol), benzyl chloride (0.14 mL, 1.25 mmol), and NaI (50 mg, 0.33 mmol) in acetonitrile (10 mL) was heated under reflux for 18 h. To the cold mixture, CH 2 Cl 2 (20 mL) was added and the solution was washed with water (2 Â 20 mL). The organic layer was dried with anhyd Na 2 SO 4 , filtered, and concentrated in vacuo. The residue was crystallized from EtOAc to give amine 8 (283 mg, 85% yield), mp 155-157°C. IR 2932 IR , 2922 IR , 2851 IR , 1600 IR , 1493 IR , 1449 IR , 1382 IR , 1321 IR , 1198 IR , 1158 IR , 1122 , 699 cm À1 . (9)], 51.9 (CH 2 , CH 2 -C 6 H 5 ), 70.2 (CH, C3), 86.4 (C, C1), 126.1 (CH, C para ), 127.84 (CH) and 127.88 (CH) (C meta and C ortho ), 142.2 (C, C ipso ). MS (EI), m/z (%): 333 (M Å+ , 11), 276 (11), 242 (20) , 148 (15), 106 (36), 91 (100). Anal. Calcd for C 23 H 27 NO (333.47): C, 82.84; H, 8.16; N, 4.20. Found: C, 82.59; H, 8.19; N, 4.12. 4.1.9. (3-Methyl-2-oxaadamant-1-yl)hydrazine hydrochloride, 9aÁHCl
A mixture of alcohol 5a (10.5 g, 62.5 mmol), hydrazine hydrate (68.5 mL, 98% aq solution, 1.38 mol), and concd HCl (2.2 mL) was refluxed for 18 h. The suspension was cooled (ice-bath) and the solid hydrazine was filtered off and dried under reduced pressure. Its hydrochloride (11.5 g, 84% yield) was obtained by adding an excess of Et 2 OÁHCl to a solution of the hydrazine in EtOAc (10 mL). The analytical sample of 9aÁHCl was obtained by crystallization from MeOH/Et 2 O, mp 181À183°C. IR 3180, 2923 IR 3180, , 2681 IR 3180, , 1690 IR 3180, , 1611 IR 3180, , 1528 IR 3180, , 1509 IR 3180, , 1497 IR 3180, , 1383 IR 3180, , 1106 IR 3180, , 1077 From 5b (5.60 g, 30.7 mmol), hydrazine hydrate (33.5 mL, 98% aq solution, 0.68 mol), and concentrated HCl (1.1 mL) and following the procedure described for 9a, the hydrazine 9b was obtained as its hydrochloride (3.20 g, 45% yield). The analytical sample of 9bÁHCl was obtained by crystallization from 2-propanol/hexane, mp 199À200°C. IR 3176, 2914 2-propanol/hexane, mp 199À200°C. IR 3176, , 2852 2-propanol/hexane, mp 199À200°C. IR 3176, , 2682 2-propanol/hexane, mp 199À200°C. IR 3176, , 1609 2-propanol/hexane, mp 199À200°C. IR 3176, , 1529 2-propanol/hexane, mp 199À200°C. IR 3176, , 1515 2-propanol/hexane, mp 199À200°C. IR 3176, , 1442 2-propanol/hexane, mp 199À200°C. IR 3176, , 1383 2-propanol/hexane, mp 199À200°C. IR 3176, , 1206 2-propanol/hexane, mp 199À200°C. IR 3176, , 1138 2-propanol/hexane, mp 199À200°C. IR 3176, , 1079 . 1 H NMR 0.91 (t, J = 7.5 Hz, 3H, CH 3 -CH 2 ), 1.50 (q, J = 7.5 Hz, 2H, CH 3 -CH 2 ), 1.58 [dm, J = 12.5 Hz, 2H, 4(10) -H ax ], 1.62 [dm, J = 12.5 Hz, 2H, 4(10) -H eq ], 1.67 [dm, J = 11.5 Hz, 2H, 8(9) -H ax ], 1.74 [dm, J = 11.5 Hz, 2H, 8(9) 197.1648 . Found: 197.1644 hydrazine hydrochloride, 9cÁHCl
From 5c (1.85 g, 8.04 mmol), hydrazine hydrate (8.8 mL, 98% aq solution, 0.18 mol), and concentrated HCl (0.3 mL) and following the procedure described for 9a, the hydrazine 9c was obtained as its hydrochloride (1.39 g, 62% yield). The analytical sample of 9bÁHCl was obtained by crystallization from methanol, mp 203À204°C. IR 3219, 2948 , 2851 , 2669 , 1573 , 1514 , 1209 -H ax ], 1.85 [dm, J = 12.5 Hz, 2H, 4(10) -H ax ], 1. 86-1.92 [complex signal, 3H, 8(9) -H eq and 6-H anti ], 1.98 (dm, J = 13.5 Hz, 1H, 6-H syn ), 2.07 [dm, J = 12.5 Hz, 2H, 4(10) -H eq ], 2.45 [m, 2H, 5(7)-H], 4.86 (s, mobile H), 7.22 (tm, 1H, J = 7.5 Hz, Ar-H para ), 7.32 (tm, J = 7.5 Hz, 2H, Ar-H meta ), 7.52 (dm, J = 7.5 Hz, 2H, Ar-H ortho ). 13 C NMR (100.6 MHz) 30.0 [CH, C5 (7)], 34.8 (CH 2 , C6), 37.6 [CH 2 , C8 (9)], 41.7 [CH 2 , C4(10)], 78.1 (C, C3), 85.1 (C, C1), 125.3 (CH, Ar-C ortho ), 127.9 (CH, Ar-C para ), 129.1 (CH, Ar-C meta ), 147.9 (C, Ar-C ipso ). MS (EI), m/z (%): 245 (14) , 64.16; H, 7.54; N, 9.98; Cl, 12.63. Found: C, 64.03; H, 7.42; N, 9.86; Cl, 12.51. 4.1.12. (3-Methyl-2-oxaadamant-1-yl)amine hydrochloride, 10aÁHCl
A mixture of 9aÁHCl (6.70 g, 30.6 mmol) and PtO 2 (20 mg) in absolute EtOH (200 mL) was hydrogenated at 1 atm and room temperature for 4 days. The suspension was filtered, the residue was washed with absolute EtOH, and the combined organic filtrates were concentrated in vacuo to dryness. The obtained white residue was taken in water (100 mL), the solution was basified with 2 N NaOH, and was extracted with EtOAc (5 Â 80 mL). The combined organic extracts were dried with anhyd Na 2 SO 4 , and concentrated in vacuo to dryness. The residue was taken in the minimum amount of AcOEt and the solution was treated with an excess of a solution of HCl in Et 2 O. The precipitate was filtered and washed with Et 2 O to give 10aÁHCl (3.60 g, 58% yield). The analytical sample of 10aÁHCl was obtained by crystallization from MeOH, mp 268À269°C. IR 2966 IR , 2924 IR , 2852 IR , 1582 IR , 1516 IR , 1379 IR , 1235 IR , 1060 IR , 1038 IR , 1005 , 8.96; N, 6.73; Cl, 17.03. Found: C, 57.78; H, 8.92; N, 7.01; Cl, 17.34. 4.1.20 . N-Methyl(3-ethyl-2-oxaadamant-1-yl)amine hydrochloride, 15ÁHCl
A mixture of 14ÁHCl (390 mg, 1.21 mmol) and 10% Pd/C (50% in water, 10 mg) in absolute EtOH (80 mL) was hydrogenated at 38 atm and 100°C for 24 h. The suspension was filtered, the residue was washed with EtOH, and the combined organic filtrates were treated with an excess of a solution of HCl in Et 2 O. The solution was concentrated in vacuo and the residue was crystallized from MeOH/Et 2 O to give the analytical sample of 15ÁHCl (240 mg, 85% yield), mp 155À156°C. IR 2968 IR , 2931 IR , 2848 IR , 2706 IR , 2592 IR , 1561 IR , 1474 IR , 1118 IR , 1068 IR , 1057 IR , 1028 , 972 cm À1 . 1 H NMR 0.92 (t, J = 7.5 Hz, 3H, CH 3 CH 2 ), 1.50 (q, J = 7.5 Hz, 2H, CH 3 CH 2 ), 1.63 [dm, J = 12.5 Hz, 2H, 4(10)-H ax ], 1.72 [dm, J = 12.5 Hz, 2H, 4(10)-H eq ], 1.84 [s, 2H, 6-H anti and 6-H syn ], 1.87 [dm, J = 13.0 Hz, 2H, 8(9)-H ax ], 1.91 [dm, J = 13.0 Hz, 2H, 8(9)-H eq ], 2.43 [broad s, 2H, 5(7)-H], 2.63 (s, 3H, NCH 3 ). 13 C NMR (100.6 MHz) 7.1 (CH 3 , CH 3 CH 2 ), 25.5 (CH 3 , NCH 3 ), 29.8 [CH, C5 (7)], 34.6 (CH 2 , C6), 35.2 (CH 2 , CH 3 CH 2 ), 37.0 [CH 2 , C8 (9)], 38.6 [CH 2 , C4(10)], 78.5 (C, C3), 86.5 (C, C1). MS (EI, CH 4 ), m/z (%): 196 (11), 195 (M Å+ , 84), 180 (11), 166 (69), 138 (26), 124 (56), 108 (37), 99 (62), 95 (31), 74 (28), 73 (100), 71 (51). Anal. Calcd for C 12 H 21 NOÁ1.1HClÁ0.5H 2 O (242.60): C, 59.41; H, 9.58; N, 5.77; Cl, 15.34. Found: C, 59.41; H, 9.89; N, 6.11; Cl, 15 .61.
NMDA receptor antagonist activity
The functional assay of antagonist activity at NMDA receptors was performed using primary cultures of cerebellar granule neurons, which were prepared according to established protocols. 11 Cells were grown on 10 mm poly-L-lysine-coated glass cover slips, and used for the experiments after 7-14 days in vitro. Cells were loaded with 6 lM Fura-2 AM (Invitrogen-Molecular Probes) for 45 min. Afterwards, the coverslip was mounted on a quartz cuvette containing a Locke-Hepes buffer using a special holder. Measurements were performed using a Perkin-Elmer LS-50B fluorometer equipped with a fast-filter accessory, under mild agitation and at 37°C. Analysis from each sample was recorded real-time during 1200 s. After stimulation with NMDA or glutamate (100 lM, in the presence of 10 lM glycine), increasing cumulative concentrations of the compound to be tested were added. The percentages of inhibition at every tested concentration were analyzed using a nonlinear regression curve fitting (variable slope) by using the software GraphPad Prism 4.0.
Antiviral evaluation
The antiviral activity of the compounds was determined in established cell culture assays using a selection of DNA and RNA viruses, including three subtypes of influenza virus [A/Puerto Rico/8/34 (H1N1); A/Hong Kong/7/87 (H3N2); and B/Hong Kong/5/72]. 13 The compounds 0 inhibitory effect on virus replication as well as their cytotoxicity was monitored by microscopical examination, and confirmed by the colorimetric MTS cell viability assay.
T. brucei culturing and drug test
Cultures of bloodstream form T. brucei (strain 427) were maintained at 37°C in modified Iscove 0 s medium (pH 7.4). 14 Trypanocidal activity was assessed by growing parasites for 48 h in the presence of various drug concentrations to determine the levels which inhibited growth by 50% (IC 50 ) and 90% (IC 90 ). In the case of untreated cultures (volume 4 mL), cell densities increased from 0.5 Â 10 4 to 1 Â 10 6 cells mL À1 over this period. Experiments were performed in triplicate. Cell densities at each drug concentration were determined using a hemocytometer (Weber Scientific International Ltd), and drug sensitivity was expressed as a percentage of growth of control cells.
